These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11196 related articles for article (PubMed ID: 1396075)

  • 41. [Efficacy of ondansetron in acute and delayed cisplatin-induced nausea and vomiting].
    Depierre A
    Bull Cancer; 1996 Feb; 83(2):147-53. PubMed ID: 8652909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral ondansetron and intravenous dexamethasone in the prevention of cisplatin-induced emesis. A phase II trial in women.
    Franchi M; Donadello N; Zanaboni F; Tusei A; Scorbati E
    Oncology; 1995; 52(6):509-12. PubMed ID: 7478441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ondansetron suppository: an effective treatment for the prevention of emetic disorders induced by cisplatin-based chemotherapy. French Ondansetron Study Group.
    Fumoleau P; Giovannini M; Rolland F; Votan B; Paillarse JM
    Oral Oncol; 1997 Sep; 33(5):354-8. PubMed ID: 9415336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Aprepitant for the prevention of cisplatine induced nausea and vomiting: an observational study].
    Galy G; Labidi SI; Tissier F; Combes JD; Auger A; Favier B; Latour JF
    Bull Cancer; 2009 Feb; 96(2):141-5. PubMed ID: 19258220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients.
    Rithirangsriroj K; Manchana T; Akkayagorn L
    Gynecol Oncol; 2015 Jan; 136(1):82-6. PubMed ID: 25449310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single 8 mg dose of oral ondansetron failed to prevent FAC chemotherapy-induced acute nausea and vomiting.
    Bosnjak SM; Neskovic-Konstantinovic ZB; Jovanovic-Micic DJ; Mitrovic LB; Radulovic SS
    J Chemother; 1996 Aug; 8(4):315-8. PubMed ID: 8873840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ondansetron versus ondansetron, dexamethasone, and chlorpromazine in the prevention of nausea and vomiting associated with multiple-day cisplatin chemotherapy.
    Fox SM; Einhorn LH; Cox E; Powell N; Abdy A
    J Clin Oncol; 1993 Dec; 11(12):2391-5. PubMed ID: 8246028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.
    De Mulder PH; Seynaeve C; Vermorken JB; van Liessum PA; Mols-Jevdevic S; Allman EL; Beranek P; Verweij J
    Ann Intern Med; 1990 Dec; 113(11):834-40. PubMed ID: 2146911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
    Kenward H; Elliott J; Lee T; Pelligand L
    BMC Vet Res; 2017 Aug; 13(1):244. PubMed ID: 28814338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Examination of anti-emetic effect and safety of multiple intravenous doses of ondansetron in patients receiving nonplatinum anti-cancer drugs].
    Nukariya N; Niitani H; Taguchi T; Furue H; Ota K; Tsukagoshi S; Ariyoshi Y; Ikeda M; Akasaka Y; Ohta J
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1375-85. PubMed ID: 1386978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-HT3 receptor antagonists in the control of cisplatin-induced delayed emesis.
    Ossi M; Anderson E; Freeman A
    Oncology; 1996 Jun; 53 Suppl 1():78-85. PubMed ID: 8692556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens.
    Martoni A; Angelelli B; Guaraldi M; Strocchi E; Pannuti F
    Eur J Cancer; 1996 Jan; 32A(1):82-5. PubMed ID: 8695248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomised, parallel-group study. The Ondansetron and Granisetron Emesis Study Group.
    Ruff P; Paska W; Goedhals L; Pouillart P; Rivière A; Vorobiof D; Bloch B; Jones A; Martin C; Brunet R
    Oncology; 1994; 51(1):113-8. PubMed ID: 8265095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of ondansetron against emesis induced by a multiple-day cisplatin-based chemotherapy regimen for malignant lymphoma.
    Kamiya T; Sakurai M; Kikuchi T; Okayama M; Mizuno K; Tanigawa T; Koda Y; Kato J; Mori T
    Hematology; 2021 Dec; 26(1):945-949. PubMed ID: 34789076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetron Study Group.
    Seynaeve C; Schuller J; Buser K; Porteder H; Van Belle S; Sevelda P; Christmann D; Schmidt M; Kitchener H; Paes D
    Br J Cancer; 1992 Jul; 66(1):192-7. PubMed ID: 1386245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ondansetron for the prevention of emesis induced by high-dose cisplatin. A multi-center dose-response study.
    Khojasteh A; Sartiano G; Tapazoglou E; Lester E; Gandara D; Bernard S; Finn A
    Cancer; 1990 Sep; 66(6):1101-5. PubMed ID: 2144788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study.
    Köseoglu V; Kürekçi AE; Sarici U; Atay AA; Ozcan O
    Eur J Pediatr; 1998 Oct; 157(10):806-10. PubMed ID: 9809818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study.
    Gebbia V; Testa A; Cannata G; Gebbia N
    Anticancer Drugs; 1996 Sep; 7(7):734-7. PubMed ID: 8949983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of ondansetron with customary treatment in the prophylaxis of nausea and emesis induced by non-cisplatin containing chemotherapy.
    Jantunen IT; Flander MK; Heikkinen MI; Kuoppala TA; Teerenhovi L; Kataja VV
    Acta Oncol; 1993; 32(4):413-5. PubMed ID: 8369129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination of transcutaneous electrical nerve stimulation and ondansetron in preventing cisplatin-induced emesis.
    Ozgür Tan M; Sandikçi Z; Uygur MC; Arik AI; Erol D
    Urol Int; 2001; 67(1):54-8. PubMed ID: 11464117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 560.